Intravenous and oral administration of amiodarone for the management of recent onset atrial fibrillation (AF): a randomized, digoxin and disopyramide controlled trial
Completed
- Conditions
- Atrial fibrillationCirculatory System
- Registration Number
- ISRCTN87656977
- Lead Sponsor
- Greek National Health Service (Greece)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 223
Inclusion Criteria
Patients with recent onset atrial fibrillation
Exclusion Criteria
1. Age <18 years
2. Baseline systolic blood pressure <100 mmHg
3. Known thyroid disease
4. Serum potassium <3.5 mmol/l
5. Pre-treatment with any antiarrhythmic drug
6. Documented permanent AF
7. Atrial flutter and corrected heart rate (QTc) interval >440 msec
8. The duration of tachyarrhythmia estimated by medical history
9. The current guidelines regarding prevention of thromboembolism are also followed
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Restoration of sinus rhythm
- Secondary Outcome Measures
Name Time Method Blood pressure monitoring